Loading…
news
Hosted by Jeff Martin · news · EN · 29 episodes
Biotech's Live show. Dedicated to covering the early stage signals that indicate what's next in the industry.
Required Pod Score for this show. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Verified email
Booking probability
31%
Guest openness
Selective
Sign up to generate a grounded pitch for The Biotech Voyager.
Signup to Generate a PitchThe Biotech Voyager is a news podcast hosted by Jeff Martin, with 29 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.
Jeff Martin hosts The Biotech Voyager, a news show with 29 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
The Biotech Voyager
Welcome to The Biotech Voyager. It's the show that covers what's next in biotech, mapping the early-stage signals before they become big news.
The Biotech Voyager
Welcome to The Biotech Voyager, the show that covers what's next in biotech.
The Biotech Voyager
Jack Gugel, co-founder and CEO of Arkana Therapeutics, joins the show to explain how a molecule discovered in Burmese python metabolism could offer an alternative to GLP-1 drugs, why pythons are the perfect model organism for studying extreme metabolic swings, and why he thinks every PhD should end with a company instead of a postdoc application. Arkana spun out of a University of Colorado Boulder lab that's spent 20 years studying how Burmese pythons survive a year without eating, then consume a meal their own body weight, spiking their metabolism 40x in the process. That extreme biology led to the discovery of a novel appetite suppressant molecule that acts only on the brain, unlike GLP-1 drugs, which also slow gastric emptying and cause GI side effects in roughly half of patients. Jack walks through the science, the company's origin story, and where the platform goes next. Chapters 00:00:00 Intro and meet Jack Gugel, CEO of Arkana Therapeutics 00:01:03 How studying pythons for a PhD led to a biotech 00:02:45 The discovery: a python molecule that suppresses appetite 00:04:26 GLP-1 vs. Arkana's molecule, why the side effects differ 00:06:10 From 200 metabolites to one drug candidate 00:07:04 How they actually manufacture it (they're not farming pythons) 00:08:46 The origin story: an Oklahoma road trip and a CU Boulder lab 00:11:00 Why every PhD should end with a company 00:14:16 The eureka moment: a drug target with zero competition 00:16:06 The flip side: could this help cancer and ICU patients? 00:17:36 Arkana's next steps and funding stage 00:18:49 The other half of weight loss: burning calories like a python 00:20:27 Inside the lab: how they pull compounds from snakes 00:24:20 Other biotechs betting on extreme animal biology 00:25:47 What's being slept on in biotech right now New episodes every Tuesday and Thursday at 11:00 AM. #biotech #arkana #GLP1
The Biotech Voyager
Welcome to The Biotech Voyager. It's the show that covers the early-stage biotech space, uncovering the companies that are going to be a big deal in a couple of years.
The Biotech Voyager
Welcome to the Biotech Voyager. It's the show that covers what's next in biotech. Drop a question in the chat to be part of the conversation .
Recent guests on The Biotech Voyager. Study who booked and why before you pitch.
Sponsor detection runs nightly. Check back soon.
Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
FAQs
If you have a concern about deliverability, AI quality, data privacy, or whether this will actually work for your specific situation, it's probably answered below.
Founder Solo gives you 50 AI pitches per month using the credit model (Standard pitches cost 1 credit, Enriched pitches cost 2). Founder Pro raises that to 200 credits per month and adds full Booking Probability access, unlimited Magic Match, Apollo enrichment credits, and data export capabilities. Both plans use the same credit system, so you can stretch your monthly budget further by using Standard-mode drafting.
Agency tiers have no base fee. You pay per managed client and per talent profile. Agency Standard is $199 per client per month; Agency Pro is $399 per client per month. Both add $39 per talent profile per month. Your own team's user seats are always free.
A talent profile represents one person (founder, executive, or spokesperson) you are booking onto podcasts. It includes their bio, topics, headshots, and outreach history. Team plans include 5 profiles; agency plans are pay-as-you-go.
Yes, at any time. Upgrades take effect immediately; downgrades apply at the end of the current billing period. Contact support if you need help migrating between plan families.
Every paid plan includes a 15-day free trial. Your card is saved at signup but you will not be charged until day 16. Cancel any time from your dashboard.
You keep access until the end of your current billing period. No charges after that. Your data is retained for 30 days in case you reactivate.
Yes. Select Annual on the pricing toggle and the discounted price is applied automatically at checkout. The annual price shown is the full year cost.
That is our Enterprise tier. Contact our sales team and we will build a custom plan with volume pricing, a dedicated account manager, and SLA guarantees.
